Feud or Friend? The Role of the miR-17-92 Cluster in Tumorigenesis
Journal:
Current Genomics
Volume:
11
Page:
129-135
Author(s):
Jie Xiang and Ji Wu
Towards Characteristics of Photodynamic Drugs Specifically Aimed at Microvascular Diseases
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
10
Page:
332-341
Author(s):
Jingquan Zhao, Hong Deng, Jie Xie, Xin Liu, Yang Zhang, Naiyan Huang and Ying Gu
Tubulin-Targeting Agents in Hybrid Drugs
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
609-639
Author(s):
E. C. Breen and J. J. Walsh
Valproic Acid in the Complex Therapy of Malignant Tumors
Journal:
Current Drug Targets
Volume:
11
Page:
361-379
Author(s):
J. Hrebackova, J. Hrabeta and T. Eckschlager
Telomere Maintenance as Therapeutic Target in Embryonal Tumours
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
10
Page:
196-212
Author(s):
T. Shalaby, E. Hiyama and M.A. Grotzer
Peptidic Tumor Targeting Agents: The Road from Phage Display Peptide Selections to Clinical Applications
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
1040-1054
Author(s):
Kathlynn C. Brown
Tumor Markers: The Potential of “Omics” Approach
Journal:
Current Molecular Medicine
Volume:
10
Page:
249-257
Author(s):
M. Sikaroodi, Y. Galachiantz and A. Baranova
ROCK Inhibitors as Emerging Therapeutic Candidates for Sarcomas
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
127-134
Author(s):
S. Micuda, D. Rosel, A. Ryska and J. Brabek
Understanding FOXO, New Views on Old Transcription Factors
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
135-146
Author(s):
F. Zanella, W. Link and A. Carnero
IP6 in Cancer Therapy: Past, Present and Future
Journal:
Current Cancer Therapy Reviews
Volume:
6
Page:
1-12
Author(s):
Agata Matejuk and Abulkalam Shamsuddin